To determine whether MYC contributed to the recovery effect of metformin in F. nucleatum-inhibited miR-361-5p, we first detected the expression of MYC in CRC cells treated with metformin and F. nucleatum. This evidence concerns the gene MYC and colorectal carcinoma.